A detailed history of Ctc LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ctc LLC holds 2,238 shares of LLY stock, worth $1.69 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,238
Previous 14,977 85.06%
Holding current value
$1.69 Million
Previous $13.6 Million 85.38%
% of portfolio
0.05%
Previous 0.44%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $9.84 Million - $12.2 Million
-12,739 Reduced 85.06%
2,238 $1.98 Million
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $8.02 Million - $10.1 Million
11,068 Added 283.14%
14,977 $13.6 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $2.31 Million - $3.1 Million
3,909 New
3,909 $3.04 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ctc LLC Portfolio

Follow Ctc LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ctc LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ctc LLC with notifications on news.